Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumour Response,”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT06521775
What this trial is testing

An Investigational Scan (Ga-68 PSMA-11 PET/CT) for the Detection of Therapy Response in Patients With Metastatic Adenoid Cystic Carcinoma

Who this might be right for
Metastatic Adenoid Cystic Carcinoma
Mayo Clinic 6
Large-scale testing (Phase 3)Study completedNCT00002930
What this trial is testing

PET Scan in Patients With Lung and Esophageal Cancers That May Be Removed by Surgery

Who this might be right for
Esophageal CancerLung Cancer
Memorial Sloan Kettering Cancer Center 75
Testing effectiveness (Phase 2)Active Not RecruitingNCT03712202
What this trial is testing

Brentuximab Vedotin and Nivolumab in Treating Patients With Early Stage Classic Hodgkin Lymphoma

Who this might be right for
Ann Arbor Stage I Hodgkin LymphomaAnn Arbor Stage I Mixed Cellularity Classic Hodgkin LymphomaAnn Arbor Stage I Nodular Sclerosis Classic Hodgkin Lymphoma+11 more
City of Hope Medical Center 155
Not applicableUnknownNCT04277195
What this trial is testing

Developing a Diagnostic Tool to Predict Response to Chemotherapy

Who this might be right for
Breast Cancer
Nottingham University Hospitals NHS Trust 4,750
Not applicableUnknownNCT03892577
What this trial is testing

Real-world Study for Patients With Advanced Hepatobiliary Tumors

Who this might be right for
Objective Response RateProgression-free SurvivalOverall Survival+4 more
Peking Union Medical College Hospital 3,000
Not applicableLooking for participantsNCT05985330
What this trial is testing

Pilot Study of the Contribution of Fractional Exhaled Nitric Oxide as a Prognostic Marker of Response to Anti-PD-L1 Immunotherapy in Non-small Cell Lung Cancer

Who this might be right for
Metastatic Non-small Cell Lung Cancer
Centre Hospitalier Universitaire Dijon 56
Not applicableUnknownNCT05161728
What this trial is testing

PSMA Response in Metastasized Hormone Sensitive Prostate Cancer

Who this might be right for
Prostate Cancer
Roderick van den Bergh 150
Testing effectiveness (Phase 2)Study completedNCT03642067
What this trial is testing

Study of Nivolumab and Relatlimab in Patients With Microsatellite Stable (MSS) Advanced Colorectal Cancer

Who this might be right for
Microsatellite Stable (MSS) Colorectal AdenocarcinomasColorectal Adenocarcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 59
Very early researchEnded earlyNCT02591654
What this trial is testing

MRI and PET to Assess Pembrolizumab Response

Who this might be right for
Malignant Melanoma, Metastatic
Columbia University 6
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07702851
What this trial is testing

Polatuzumab Vedotin and Glofitamab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma Within 12 Months After R-CHOP

Who this might be right for
Diffuse Large B-cell Lymphoma
Yonsei University 47
Not applicableUnknownNCT02208128
What this trial is testing

Molecular Determinants for Therapy Response on Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Heidelberg University 4
Testing effectiveness (Phase 2)Study completedNCT01696565
What this trial is testing

PG2 Phase I/II Clinical Study Intravenously Administered in Patients With Advanced Malignancy

Who this might be right for
Neoplasm MetastasisNeoplasm Recurrence
PhytoHealth Corporation 32
Early research (Phase 1)Study completedNCT00104845
What this trial is testing

Vaccine Therapy in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Memorial Sloan Kettering Cancer Center 19
Very early researchStudy completedNCT03771157
What this trial is testing

Serologic Response to SHINGRIX Vaccine in Patients With CLL and WM Treated With BTK Inhibitors

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)Waldenstrom Macroglobulinemia (WM)
University of Rochester 33
Testing effectiveness (Phase 2)UnknownNCT02955628
What this trial is testing

RICE-ibrutinib in Relapsed DLBCL

Who this might be right for
Diffuse Large B Cell LymphomaDiffuse Large B-Cell Lymphoma Recurrent
Singapore General Hospital 34
Testing effectiveness (Phase 2)Study completedNCT04696757
What this trial is testing

Non-OpeRative MANagement of Rectal Cancer Patients

Who this might be right for
Rectal CancerChemoradiotherapyWatch & Wait
Kangbuk Samsung Hospital 18
Not applicableUnknownNCT00897039
What this trial is testing

Laboratory Study in Predicting Tumor Response to Chemotherapy in Patients With Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Southeastern Gynecologic Oncology 60
Not applicableLooking for participantsNCT06909201
What this trial is testing

Hyperpolarized Xenon-129 Magnetic Resonance Imaging in Lung Cancer Patients Receiving Radiation Therapy for Investigating Radiation-response and Toxicity

Who this might be right for
Lung Cancer
M.D. Anderson Cancer Center 70
Not applicableStudy completedNCT01002937
What this trial is testing

Novel Prognostic Markers in Renal Cancer

Who this might be right for
Renal Cell Carcinoma
Royal Marsden NHS Foundation Trust 182
Not applicableStudy completedNCT03730545
What this trial is testing

Effect of Enteral Immunonutrition on Immune, Inflammatory Markers and Nutritional Status in Patients Undergoing Gastrectomy for Gastric Cancer

Who this might be right for
Gastric CancerEnteral Immunonutrition
West China Hospital 124
Next Page